Abstract

Background: Paclitaxel, Docetaxel and Vinorelbine exert anti-tumor activity by interfering with microtubule dynamics, leading to mitotic arrest. Though these agents are commonly used in treatment of breast cancers, therapy failures are noted due to innate and acquired chemoresistance. Real-time monitoring of chemoresistance towards such treatment agents is an unmet clinical need since conventional methods for chemoresistance profiling (CRP) necessitate invasive biopsies to obtain viable tumor tissue. We evaluated the utility of peripheral blood Circulating Tumor Associated Cells (C-TACs) for real-time non-invasive CRP in breast cancers.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.